Skip to main content

Diversity In Science

28th January 2022
  • Dr Ghina Halabi & Dr Jason Mellad will headline first 2022 CETC event
  •  Seminar will also debate why only 4% of Cambridge’s biomedical companies have a female CEO

The Cambridge Enterprise and Technology Club will host Diversity in Science its first seminar in 2022 at The Lab Cocktail Bar on the 15th of February from 1730-1930.

The seminar will seek to understand and challenge the nature of diversity in science and technology in the UK with guest speakers – space scientist and social entrepreneur, Dr Ghina Halabi and CEO and co-founder of Start Codon, the bioscience accelerator, Dr Jason Mellad.

Dr Ghina Halabi works to further the gender equality agenda in space and STEM through mentorship with the support of networks like Space4Women. Ghina is an astrophysicist, founder of She Speaks Science and an UNOOSA[1] STEM mentor.

Dr Jason Mellad is the CEO of Start Codon. An experienced bioscience leader with a demonstrated history in the biotechnology industry he is skilled in innovation management, oncology, molecular biology as well as patent law and biotechnology.

George Neville-Jones, Secretary of the CETC and local director at Metro Bank’s Cambridge store said; “The CETC has been running seminars on the bleeding edge of science and technology for over twenty years. This free event will tackle one of the thorniest issues at hand: Diversity in Science. For example, only 4% of Cambridge’s biomedical companies have a female CEO2. I know our speakers are looking forward to debating this subject in what will be a unique and interactive seminar.”

Every Metro Bank store has customer-facing local directors who are there to support local business owners with their banking and financial needs to help them thrive and grow.

Tickets can be  booked at  Diversity in Science - a Cambridge Enterprise and Technology Club seminar Tickets, Tue 15 Feb 2022 at 17:30 | Eventbrite


[1] The United Nations Office for Outer Space Affairs (UNOOSA)

2 Cambridge Science Park’s Biomedical Cluster Report 2022